World Health Organization: New guidelines for the treatment of adult obesity based on GLP-1 therapy are scheduled to be officially released in September.

Journalists have learned that the World Health Organization is developing new guidelines based on GLP-1 for the treatment of adult obesity, which are planned to be officially released in September 2025. The guidelines are being developed by an independent guideline development group, consisting of experts in the field of obesity, epidemiology, clinical management, pharmacology, health economics, public health program specialists, and policy makers, to ensure that the guidelines meet the strict standards of the World Health Organization. It is reported that the purpose of these guidelines is to clarify the clinical indications, applications, and considerations for the use of GLP-1 RAs. These guidelines are expected to be the first formal recommendation by the World Health Organization for the use of weight loss drugs in the treatment of adult obesity. This move marks a significant shift in policy by this global health organization in addressing the increasingly serious obesity crisis.